Innovations

More biosimilars marketed in Germany, Switzerland than U.S.

0

More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.

Get your groove on with a pair of Sennheiser Momentum 4 headphones at their lowest price ever

Previous article

On world AIDS day, White House announces plan to end epidemic by 2030

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations